PELI Logo
title

References - Expert Understanding of Clinical Magnesium Therapy

  1. DiNicolantonio, J.J., J.H. O'Keefe, and W. Wilson, Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart, 2018. 5(1): p. e000668-e000668.
  2. Ross, A.C., et al., Modern Nutritin in Health and Disease. 11th ed. 2014, Philadelphia: Lippincott Williams & Wilkins.
  3. Higdon, J. Magnesium. 2018; Available from: https://lpi.oregonstate.edu/mic/minerals/magnesium#deficiency.
  4. Kostov, K., Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. International Journal of Molecular Sciences, 2019. 20(6): p. 1351.
  5. Gröber, U., J. Schmidt, and K. Kisters, Magnesium in prevention and therapy. Nutrients, 2015. 7(9): p. 8199-8226.
  6. Bohn, T. Thesis: Magnesium Absorption in Humans. Germany, Swiss Federal Institute of Technology Zurich, 2003.
  7. Ranade, V. and J. Somberg, Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. American Journal of Therapeutics, 2001. 8: p. 345-357.
  8.  Kappeler, D., et al., Higher bioavailability of magnesium citrate as compared to magnesium oxide shown by evaluation of urinary excretion and serum levels after single-dose administration in a randomized cross-over study. BMC Nutrition, 2017. 3(1): p. 7.
  9. Rylander, R., Bioavailability of Magnesium Salts – A Review. Journal of Pharmacy and Nutrition Sciences, 2014. 4: p. 57-59.
  10.  Kumar, A., et al., The metabolism and significance of homocysteine in nutrition and health. Nutrition & Metabolism, 2017. 14(1): p. 78.
  11. Torres, E. and M. Ayala, 6.24.5.3 Alcohol Dehydrogenase, in Comprehensive Inorganic Chemistry II. 2013, Elsevier Ltd.
  12. Gueux, E., et al., Reduction of Plasma Lecithin—Cholesterol Acyltransferase Activity by Acute Magnesium Deficiency in the Rat. The Journal of Nutrition, 1984. 114(8): p. 1479-1483.
  13. Hall Kathryn, T., et al., Catechol‐O‐Methyltransferase and Cardiovascular Disease: MESA. J Am Heart Assoc, 2019. 8(24): p. e014986.
  14. Bastos, P., et al., Effect of a natural mineral-rich water on catechol-O-methyltransferase function. Magnesium Research, 2014. 27(3): p. 131-141.
  15. Ploceniak, C., [Bruxism and magnesium, my clinical experiences since 1980]. (0035-1768 (Print)).
  16. Supakatisant, C. and V. Phupong, Oral magnesium for relief in pregnancy-induced leg cramps: a randomised controlled trial. Matern Child Nutr, 2015. 11(2): p. 139-145.
  17. Setaro, L., et al., Magnesium status and the physical performance of volleyball players: effects of magnesium supplementation. Journal of sports sciences, 2014. 32: p. 438-445.
  18. Kass, L.S., P. Skinner, and F. Poeira, A pilot study on the effects of magnesium supplementation with high and low habitual dietary magnesium intake on resting and recovery from aerobic and resistance exercise and systolic blood pressure. Journal of Sports Science & Medicine, 2013. 12(1): p. 144-150.
  19. Veronese, N., et al., Effect of oral magnesium supplementation on physical performance in healthy elderly women involved in a weekly exercise program: A randomized controlled trial. The American Journal Of Clinical Nutrition, 2014. 100.
  20. Ryder, K.M., et al., Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects. J Am Geriatr Soc, 2005. 53(11): p. 1875-80.
  21. Carpenter, T.O., et al., A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls. J Clin Endocrinol Metab, 2006. 91(12): p. 4866-72.
  22. Yousef, A.A. and A.E. Al-deeb, A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component. Anaesthesia, 2013. 68(3): p. 260-266.
  23. Sartori, S.B., et al., Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology, 2012. 62(1): p. 304-312.
  24. Cuciureanu, M.D. and R. Vink, Magnesium and Stress, in Magnesium in the Central Nervous System, R. Vink and M. Nechifor, Editors. 2011, University of Adelaide Press: Adelaide.
  25. Maier, J., et al., Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate. Nutrients, 2020. 12: p. 2660.
  26. Koseoglu, E., et al., The effects of magnesium prophylaxis in migraine without aura. Magnesium research : official organ of the International Society for the Development of Research on Magnesium, 2008. 21: p. 101-8.
  27. Peikert, A., C. Wilimzig, and R. Kohne-Volland, Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-center, placebo-controlled and double blinded randomized study. Cephalalgia, 1996. 16: p. 257-263.
  28. Bagis, S., et al., Is magnesium citrate treatment effective on pain, clinical parameters and functional status in patients with fibromyalgia? Rheumatol Int, 2013. 33(1): p. 167-72.
  29. Eby, G. and K. Eby, Rapid recovery from major depression using magnesium treatment. Medical Hypotheses, 2006. 67: p. 362-70.
  30. Abbasi, B., et al., The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci, 2012. 17(12): p. 1161-1169.
  31. Li, W., et al., Extracellular magnesium regulates effects of vitamin B6, B12 and folate on homocysteinemia-induced depletion of intracellular free magnesium ions in canine cerebral vascular smooth muscle cells: possible relationship to [Ca2+]i, atherogenesis and stroke. Neurosci Lett., 1999. 274(2): p. 83-86.
  32. Sobhani, A.R., et al., Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial Study. Clinical Pharmacology : Advances and Applications, 2020. 12: p. 159-169.
  33. Dibaba, D.T., P. Xun, and K. He, Dietary magnesium intake is inversely associated with serum C-reactive protein levels: Meta-analysis and systematic review. European Journal of Clinical Nutrition, 2014. 68(4): p. 510-516.
  34. Rosique-Esteban, N., et al., Dietary Magnesium and Cardiovascular Disease: A Review with Emphasis in Epidemiological Studies. Nutrients, 2018. 10(2): p. 168.
  35. Stepura, O. and A. Martynow, Magnesium orotate in severe congestive heart failure (MACH). International Journal Of Cardiology, 2008. 131: p. 293-5.
  36. Joris, P.J., et al., Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: Results of a randomized, double-blind, placebo-controlled intervention trial. American Journal of Clinical Nutrition, 2016. 103(5): p. 1260-1266.
  37. Zhang, X., et al., Effects of Magnesium Supplementation on Blood Pressure. Hypertension, 2016. 68(2): p. 324-333.
  38. Shechter, M., et al., Effects of Oral Magnesium Therapy on Exercise Tolerance, Exercise-Induced Chest Pain, and Quality of Life in Patients With Coronary Artery Disease. The American Journal Of Cardiology, 2003. 91(5): p. 517-521.
  39. Shechter, M., et al., Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. (0002-9149 (Print)).
  40. Bilovol, O., et al., Magnesium in Idiopathic Mitral Valve Prolapse. Serbian Journal of Experimental and Clinical Research, 2019.
  41. Domnitskaia, T., et al., Clinical value of the use of magnesium orotate in adolescents with syndrome of cardiac connective tissue dysplasia. Kardiologiia, 2005. 45: p. 76-81.
  42. Rosenstein, D.L., et al., Magnesium measures across the menstrual cycle in premenstrual syndrome. (0006-3223 (Print)).
  43. Rajeswari, G., et al., Study of Magnesium levels in Polycystic Ovarian Syndrome. International Journal of Advances in Scientific Research, 2016. 2: p. 54.
  44. Djurhuus, M.S., et al., Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes. (0026-0495 (Print)).
  45. Arpaci, D., et al., Associations of serum Magnesium levels with diabetes mellitus and diabetic complications. Hippokratia, 2015. 19(2): p. 153-157.
  46. Fang, X., et al., Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies. Nutrients, 2016. 8(11): p. 739.
  47. Walker, A.F., et al., Magnesium supplementation alleviates premenstrual symptoms of fluid retention. Journal of Women's Health, 1998. 7(9): p. 1157-1165.
  48. De Souza, M., et al., A Synergistic Effect of a Daily Supplement for 1 Month of 200 mg Magnesium plus 50 mg Vitamin B6 for the Relief of Anxiety-Related Premenstrual Symptoms: A Randomized, Double-Blind, Crossover Study. J Wom Health Gend Base Med, 2000. 9(2): p. 131-139.
  49. Rodríguez-Morán, M., et al., Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Advances in Chronic Kidney Disease, 2018. 25: p. 261-266.
  50. Elderawi, W.A., et al., The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients. Nutrients, 2018. 11(1): p. 44.
  51. Guerrero-Romero, F., et al., Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial. Diabetes & Metabolism, 2015. 41(3): p. 202-207.
  52. Reshetnyak, V.I., Concept of the pathogenesis and treatment of cholelithiasis. World Journal Of Hepatology, 2012. 4(2): p. 18-34.
  53. Kharb, S., et al., Role of magnesium in preeclampsia. Biomedical and Biotechnology Research Journal (BBRJ), 2018. 2: p. 178.
  54. Tsai, C.-J., et al., Long-Term Effect of Magnesium Consumption on the Risk of Symptomatic Gallstone Disease Among Men. The American Journal Of Gastroenterology, 2008. 103: p. 375-82.
  55. Zarean, E. and A. Tarjan, Effect of Magnesium Supplement on Pregnancy Outcomes: A Randomized Control Trial. Advanced Biomedical Research, 2017. 6: p. 109-109.
  56. Kennedy, D.O., B Vitamins and the Brain: Mechanisms, Dose and Efficacy--A Review. Nutrients, 2016. 8(2): p. 68-68.
  57. Tardy, A.-L., et al., Vitamins and Minerals for Energy, Fatigue and Cognition: A Narrative Review of the Biochemical and Clinical Evidence. Nutrients, 2020. 12(1): p. 228.
  58. Srivastava, S., Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age-related disorders. Clinical and Translational Medicine, 2016. 5(1): p. 25.
  59. National Institutes of Health. Fact Sheet for Health Professionals. 2020; Available from: https://ods.od.nih.gov/factsheets/Niacin-HealthProfessional/.
  60. Sakakeeny, L., et al., Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults. The Journal of Nutrition, 2012. 142(7): p. 1280-1285.
  61. Lyon, P., et al., B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease. Nutrients, 2020. 12(9): p. 2867.
  62. Gristan, Y.D. and L. Moosavi, Folinic Acid. 2020, Treasure Island, FL: StatPearls Publishing.
  63. National Institutes of Health: Office of Dietary Supplements. Fact Sheet for Health Professionals: Vitamin B12. Available from: https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/.
  64. Chambial, S., et al., Vitamin C in disease prevention and cure: an overview. Indian J Clin Biochem, 2013. 28(4): p. 314-328.
  65. Jahnen-Dechent, W. and M. Ketteler, Magnesium basics. Clinical kidney journal, 2012. 5(Suppl 1): p. i3-i14.
  66. Piste, P., D. Sayaji, and M. Avinash, Calcium and its Role in Human Body. Int J Res Pharm Biomed Sci, 2013. 4(2): p. 659-668.
  67. Abebe, W., et al., Effects of chromium picolinate on vascular reactivity and cardiac ischemia-reperfusion injury in spontaneously hypertensive rats. Pharmacol Rep, 2010. 62(4): p. 674-682.
  68. Ngala, R.A., M.A. Awe, and P. Nsiah, The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study. PLoS One, 2018. 13(7): p. e0197977-e0197977.
  69. Chen, G., et al., Chromium Activates Glucose Transporter 4 Trafficking and Enhances Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes via a Cholesterol-Dependent Mechanism. Molecular Endocrinology, 2006. 20(4): p. 857-870.
  70. Li, L. and X. Yang, The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases: Links and Interactions. Oxidative Medicine and Cellular Longevity, 2018. 2018: p. 7580707.
  71. National Institutes of Health. Fact Sheet for Health Professionals: Manganese. 2020; Available from: https://ods.od.nih.gov/factsheets/Manganese-HealthProfessional/.
  72. Pohl, H.R., J.S. Wheeler, and H.E. Murray, Sodium and potassium in health and disease. Met Ions Life Sci, 2013. 13: p. 29-47.
  73. Mattmiller, S.A., B.A. Carlson, and L.M. Sordillo, Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis. Journal of nutritional science, 2013. 2: p. e28-e28.
  74. Braun, L. and M. Cohen, Herbs & Natural Supplements: An Evidence-Based Guide. 4th ed. 2015, Sydney: Churchill Livingstone/Elsevier.
  75. Prasad, A.S., Discovery of human zinc deficiency: its impact on human health and disease. Advances In Nutrition (Bethesda, Md.), 2013. 4(2): p. 176-190.
  76. Shah, A.M., Z. Wang, and J. Ma, Glutamine Metabolism and Its Role in Immunity, a Comprehensive Review. Animals : an open access journal from MDPI, 2020. 10(2): p. 326.
  77. Swaid, F., et al., Dietary glutamine supplementation prevents mucosal injury and modulates intestinal epithelial restitution following acetic acid induced intestinal injury in rats. Nutrition & Metabolism, 2013. 10(1): p. 53.
  78. Hertz, L., The Glutamate–Glutamine (GABA) Cycle: Importance of Late Postnatal Development and Potential Reciprocal Interactions between Biosynthesis and Degradation. Frontiers in endocrinology, 2013. 4: p. 59.
  79. Schaffer, S. and H.W. Kim, Effects and Mechanisms of Taurine as a Therapeutic Agent. Biomol Ther (Seoul), 2018. 26(3): p. 225-241.
  80. Whisner, C.M. and L.F. Castillo, Prebiotics, Bone and Mineral Metabolism. Calcified Tissue International, 2018. 102(4): p. 443-479.
  81. Lu, M., et al., Role of the malate-aspartate shuttle on the metabolic response to myocardial ischemia. Journal of theoretical biology, 2008. 254(2): p. 466-475.


logo

Your one stop destination for education and clinical tools, driven by our purpose to inspire people to live better lives through natural healthcare.

Customer Care or Clinical Support

1300 654 336

or visit www.myintegria.com

© 2025, Integria is a registered trademark of Integria Healthcare (Australia) Pty Ltd

Terms of Use | Privacy | Policies